J. Arnold Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-73,762
Closed -$11.4M 24
2023
Q1
$11.4M Buy
73,762
+3,073
+4% +$483K 5.59% 9
2022
Q4
$10.9M Buy
70,689
+2,363
+3% +$349K 5.37% 10
2022
Q3
$9.02M Buy
+68,326
New +$9.59M 5.08% 5
2021
Q4
Sell
-1,366
Closed -$227K 55
2021
Q3
$227K Sell
1,366
-514
-27% -$87.8K 0.11% 36
2021
Q2
$325K Sell
1,880
-9
-0.5% -$1.49K 0.16% 36
2021
Q1
$302K Sell
1,889
-7,156
-79% -$1.23M 0.17% 36
2020
Q4
$1.52M Buy
9,045
+4,269
+89% +$693K 0.9% 15
2020
Q3
$751K Sell
4,776
-12,029
-72% -$1.97M 0.56% 16
2020
Q2
$2.82M Buy
+16,805
New +$2.64M 2.36% 7
2020
Q1
Sell
-10,225
Closed -$1.52M 45
2019
Q4
$1.52M Buy
+10,225
New +$1.4M 1.95% 14

Other funds holding FBT

J. Arnold Wealth Management's FBT Position: Q2 2023 in Review

J. Arnold Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2023, closing a stake of 73,762 shares — an estimated $11.4M sold.

J. Arnold Wealth Management first reported a position in FBT in Q4 2019 and held it in 10 quarters. The position peaked at $11.4M in Q1 2023. 249 funds tracked by Wall St. Rank hold FBT as of Q2 2023.

  • J. Arnold Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2023 after selling out during the quarter.
  • J. Arnold Wealth Management sold 73,762 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2023, an estimated $11.4M.
  • J. Arnold Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 10 quarters.
  • J. Arnold Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.4M in Q1 2023.
  • 249 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2023.

Based on J. Arnold Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.